Lithuania - Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics
Since 2014, Lithuania Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics fell by 1.7% year on year. In 2019, the country was ranked number 22 comparing other countries in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics at €119,740,673.33. Lithuania is overtaken by Serbia, which was number 21 with €229,537,315.89 and is followed by Bosnia and Herzegovina with €93,347,743.28. Germany topped the ranking with €16,376,860,638.2 in 2019, +0.5% compared to 2018. Ireland, France and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Sweden witnessed the best average annual growth at +62.7% per year, while Montenegro was the worst growing country at -6.3% per year.
Loading...
| Date | Euros |
|---|---|
| 2019 | 119,740,673.33 |
| 2018 | 103,083,964.00 |
| 2017 | 108,614,123.00 |
| 2016 | 222,179,065.00 |
| 2015 | 191,024,066.00 |
How does Lithuania rank in Sold Production of Medicaments, Containing Alkaloids or Derivatives Thereof, But Not Hormones or Antibiotics?
| # | 29 Countries | Euros | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Germany
|
16,376,860,638.20 | 2019 | +0.5 % | +3.5 % | View data | |
| 2 |
#2
Ireland
|
14,139,386,320.45 | 2019 | +21.9 % | -5.8 % | View data | |
| 21 |
#21
Serbia
|
229,537,315.89 | 2019 | +5.3 % | +2.4 % | View data | |
| 22 |
#22
Lithuania
|
119,740,673.33 | 2019 | +16.2 % | -1.6 % | View data | |
| 23 |
#23
Bosnia and Herzegovina
|
93,347,743.28 | 2019 | +2.0 % | +7.0 % | View data | |